Publication

🩸 Are we taking too much blood from our patients? A new international reflection on sample volume management highlights an often overlooked issue: diagnostic blood loss. 📌 Hospital-acquired anemia affects up to 90% of ICU patients.📌 ICU patients may lose 750–950 mL of blood during a hospitalization through diagnostic sampling.📌 Routine blood collection can use ~45 times more blood than the laboratory actually needs.📌 In the Netherlands alone, around 500,000 L of blood are discarded every year. Patient Blood Management is not only about transfusion. Preserving the patient’s own blood is also an ethical, economic and environmental responsibility. A thought-provoking article from an international group, involving Pr. Antoine Guillon from CEPRLab, working on this issue: 📖 Read the full article here:https://www.degruyterbrill.com/document/doi/10.1515/cclm-2026-1125/html

I’m very pleased to share with you the recent publication of our article in FEBS Journal. https://lnkd.in/dAxA5SPf Haddou S, David A, Lipinski O, Puertas RD, Maroteaux A, Le Goff C, Moali C, Lecaille F, Duca L. Assembly and remodeling of collagen and elastic fibers in pathophysiology: Proteases have the final cut. FEBS J. 2026 May 29. Special thanks to all the authors of this review: #SabrinaHaddou, #AlexisDavid, #OskarLipinski , #RosaDoñatePuertas, #AgatheMaroteaux, #CarineLeGoff , #CatherineMoali, #FabienLecaille, and #LaurentDuca Congratulations as well to all the partners/supports involved in this project:• Team Proteolytic enzymes and their pharmacological targeting in lung diseases, Research Center for Respiratory Diseases (#CEPR), INSERM, UMR1100, University of Tours, France• Extracellular Matrix and Cell Dynamics (#MEDyC), CNRS UMR7369, University Reims Champagne-Ardenne, France• Tissue Biology and Therapeutic Engineering (#LBTI), CNRS UMR5305, University Claude Bernard Lyon I, France• #LVTS, INSERM U1148, Université Paris Cité et Université Sorbonne Paris nord, France• #SFBMEC (Société Française de la Biologie de la Matrice Extracellulaire)• #CancéropoleGrandOuest (#RéseauMoléculesmarinesmétabolismecancer)-

📢 We are pleased to share our latest publication in European Geriatric Medicine on critical care trajectories among very old patients in France. https://link.springer.com/article/10.1007/s41999-026-01495-x Using a nationwide cohort of more than 439,000 critically ill patients, we found that intermediate care units (IMCUs) play a central role in the management of adults aged ≥80 years. 🔎 One key finding: a step-down strategy from ICU to IMCU was associated with improved one-year survival, highlighting the importance of tailored critical care pathways for older adults. 👏 Congratulations to Antoine Guillon all collaborators involved in this multidisciplinary work. CHRU de Tours CEPR INSERM Lab Université de Tours #Geriatrics #CriticalCare #ICU #Aging

😊 We are pleased to share a recent article co-authored by Antoine Guillon, published in BMC Medical Ethics. 🔍 This study explores a key question in critical care: can artificial intelligence support ICU admission decisions?Through qualitative interviews with intensivists, the authors highlight the complexity, subjectivity, and ethical dimensions of these decisions, while shedding light on both the potential and the limits of AI in this context ! 💡 A thought-provoking contribution at the intersection of medicine, ethics, and innovation. 👉 Read the article: https://link.springer.com/article/10.1186/s12910-026-01454-y

👍 Nice work from Sandra Khau and colleagues from CEPR INSERM Lab (Team “ Pathophysiology of lung infections ») in embojournal.org. They propose a didactic review summarizing the cytosolic receptors and the signaling pathways involved in antifungal innate immunity.

 😊  Very proud to share our new article published in J. Med. Chem!🎓 We showed the interest of one of our new linker technologies allowing the production of high-performance loaded immunoconjugates which present improved plasma stability and internalization within cancer cells compared to the Gold Standard T-DXd.

😊 Excited to share our latest publication in European Journal of Pharmaceutics and Biopharmaceutics on the impact of biological barriers on inhaled antibodies! 👏 This work is the result of a highly productive, collaborative, and enjoyable partnership with CSL Behring. A special thank you to @ and the entire team for their great contributions! 👉 doi.org/10.1016/j.ejpb.2025.114817

We are presenting a concise overview of the existing rationale and evidence and provide guidance for implementing inhaled antibiotics among ventilated critically ill patients, published in the American Journal of Respiratory and Critical Care Medicine.

From the ocean depths to the laboratory bench, deep sea bacteria to combat respiratory diseases.   Congratulations to Alexis DAVID for taking part in the third edition of ‘My PhD in Comics’.He collaborated with Pellichi, PhD in biology and mangaka, to create a comic strip illustrating his thesis. For the PhD students, this experience is an opportunity to learn about scientific outreach, because putting their work into pictures requires discussion and follow-up with the illustrator. He will be calling on their ability to explain their thesis subject in terms that are suitable for any audience. The aim is to show that science is accessible to everyone and that the different disciplines and approaches offer a variety of experiences.

Anti-influenza therapeutic solutions, whether preventive or curative, are sub-optimal. Antivirals currently on the market have a very short efficacy window, which calls into question their real-life effectiveness. The innovative SAChA project provides proven curative efficacy several days after the initial influenza infection. This natural metabolite of interest simultaneously targets viral multiplication and the excessive inflammatory response. It is this dual effect that confers a crucial advantage in the treatment of serious complications of influenza, surpassing the capabilities of current treatments.   Watch the video presentation of the SAChA project here :